U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07001709) titled 'Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)' on April 29.
Brief Summary: Prostate cancer often leads to bone metastases, which require adequate pain management with opioids such as oxycodone. This study investigates whether abiraterone - a drug used in the treatment of prostate cancer - affects the pharmacokinetics of oxycodone in order to improve pain management.
Study Start Date: April 12, 2024
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Pain Cancer
Intervention:
DRUG: Oxycodone oral capsule 15 mg
Single dose of 15 mg oxycodone direct release (...